Welcome to The QUEST Initiative
The Quality of life Evaluation Study (QUEST Initiative) conducted by the University of Sydney will be the world’s largest longitudinal clinical study investigating the health-related quality of life outcomes and health economic impact of medicinal cannabis on patients suffering from chronic disease.Patients accessing medicinal cannabis generally have a range of conditions and symptoms that impact their quality of life. This clinical study sets out to better understand and measure how these conditions and symptoms affect a patient’s quality of life, and determine if medicinal cannabis as a treatment option impacts quality of life over time. Participants will access discounted cannabinoid medications in the form of an oral solution.
Why go on this QUEST?
To understand if a ‘new’ medical treatment really works, or if it offers good value for money, or what the impact is on a certain condition, we need to be able to measure a person’s health and their response to a treatment. While length of life is easy to measure, quality of life is more subjective, but we can measure it by asking patients questions about different aspects of their health such as their mobility, functionality, pain or discomfort, anxiety and depression. The QUEST Initiative will measure these and other factors through online questionnaires. The de-identified results from this study will help future patients with certain diagnosed conditions to make better informed decisions about their treatment and understand the potential impact of medicinal cannabis on their overall quality of life.